Cargando…

Multimodality assessments of wild‐type transthyretin cardiac amyloidosis with no ventricular hypertrophy

While patients with transthyretin cardiac amyloidosis (ATTR‐CA) typically present with concentric or asymmetric hypertrophy, a small percentage of ATTR‐CA is known to present with ‘atypical’ cardiac morphologies such as eccentric hypertrophy or even no hypertrophy. However, detailed report of multim...

Descripción completa

Detalles Bibliográficos
Autores principales:	Iwaya, Takuma, Okada, Atsushi, Tateishi, Emi, Ohta, Yasutoshi, Morita, Yoshiaki, Ohta‐Ogo, Keiko, Izumi, Chisato
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10053176/ https://www.ncbi.nlm.nih.gov/pubmed/36335980 http://dx.doi.org/10.1002/ehf2.14220

Ejemplares similares

Grade 3 myocardial uptake in (99m)technetium-pyrophosphate scintigraphy in light chain cardiac amyloidosis
por: Okada, Atsushi, et al.
Publicado: (2021)

Multimodality Assessments of Wild-Type Transthyretin Amyloid Cardiomyopathy Presenting With Eccentric Hypertrophy and Aortic Regurgitation
por: Mori, Kazuya, et al.
Publicado: (2022)

Transthyretin derived amyloid deposits in the atrium and the aortic valve: insights from multimodality evaluations and mid-term follow up
por: Okada, Atsushi, et al.
Publicado: (2023)

Monitoring treatment response to tafamidis by serial native T1 and extracellular volume in transthyretin amyloid cardiomyopathy
por: Shintani, Yasuhiro, et al.
Publicado: (2018)

Prevalence of transthyretin amyloidosis in patients with heart failure and no left ventricular hypertrophy
por: Devesa, Ana, et al.
Publicado: (2021)

Multimodality Imaging for Diagnosing Transthyretin Cardiac Amyloidosis
por: Palot Manzil, Fathima Fijula, et al.
Publicado: (2023)

Wild-type transthyretin amyloidosis in female patients
por: Kristen, Arnt V, et al.
Publicado: (2015)

Sex Differences in Wild-Type Transthyretin Amyloidosis: An Analysis from the Transthyretin Amyloidosis Outcomes Survey (THAOS)
por: Campbell, Courtney M., et al.
Publicado: (2022)

Multimodality imaging in the diagnostic management of concomitant aortic stenosis and transthyretin-related wild-type cardiac amyloidosis
por: Cersosimo, Angelica, et al.
Publicado: (2023)

Temporal Trends of Wild-Type Transthyretin Amyloid Cardiomyopathy in the Transthyretin Amyloidosis Outcomes Survey
por: Nativi-Nicolau, Jose, et al.
Publicado: (2021)

Negative bone scintigraphy in wild-type transthyretin cardiac amyloidosis
por: Martini, Nicolò, et al.
Publicado: (2020)

Frailty in Wild-Type Transthyretin Cardiac Amyloidosis: The Tip of the Iceberg
por: Broussier, Amaury, et al.
Publicado: (2021)

Wild-Type Transthyretin Cardiac Amyloidosis in a Transplanted Heart
por: Stern, Lily K., et al.
Publicado: (2023)

Endomyocardial Biopsy for the Diagnosis of Transthyretin Cardiac Amyloidosis in the Era of Multimodality Imaging
por: Sunayama, Tsutomu, et al.
Publicado: (2021)

Multimodality imaging of simultaneous occurrence of cardiac transthyretin amyloidosis and cardiac sarcoidosis
por: Elchinova, Elena, et al.
Publicado: (2022)

Prognostic value of right ventricular native T1 mapping in pulmonary arterial hypertension
por: Asano, Ryotaro, et al.
Publicado: (2021)

Transthyretin cardiac amyloidosis
por: Tomoaia, Raluca, et al.
Publicado: (2021)

Transthyretin cardiac amyloidosis
por: Porcari, Aldostefano, et al.
Publicado: (2022)

With M-protein positive, could transthyretin amyloidosis be easily excluded? Not necessarily! Wild-type transthyretin amyloidosis with Waldenström’s macroglobulinaemia: a case report
por: Kinoshita, Haruyuki, et al.
Publicado: (2022)

A case of wild-type transthyretin amyloidosis associated with organizing pneumonia
por: Nakao, Makoto, et al.
Publicado: (2017)

Wild-Type Transthyretin Amyloidosis in Female Patients　― Consideration of Sex Differences ―
por: Ochi, Yuri, et al.
Publicado: (2021)

Prognostic value of exercise echocardiography in patients with wild-type transthyretin amyloidosis
por: Agudo, Cristina Aguilera, et al.
Publicado: (2022)

Wild-type Transthyretin Amyloidosis with Diffuse Alveolar-septal Amyloidosis Diagnosed by a Transbronchial Lung Biopsy
por: Ishida, Masaki, et al.
Publicado: (2022)

Disease progression in cardiac transthyretin amyloidosis is indicated by serial calculation of National Amyloidosis Centre transthyretin amyloidosis stage
por: Law, Steven, et al.
Publicado: (2020)

Prediction of Medium-Term Mortality in Japanese Patients With Wild-Type Transthyretin Amyloidosis
por: Ochi, Yuri, et al.
Publicado: (2020)

Targeted sequencing of selected functional genes in patients with wild-type transthyretin amyloidosis
por: Moreno-Gázquez, Inmaculada, et al.
Publicado: (2023)

Hereditary transthyretine amyloidosis in Slovenia
por: Zidar, Janez
Publicado: (2015)

Multidisciplinary Approaches for Transthyretin Amyloidosis
por: Koike, Haruki, et al.
Publicado: (2021)

Hereditary transthyretin amyloidosis overview
por: Manganelli, Fiore, et al.
Publicado: (2020)

Multimodality family screening of patients with cardiac transthyretin amyloidosis: a case of an asymptomatic patient
por: Mróz, Krystian, et al.
Publicado: (2023)

EGCG-Mediated Protection of Transthyretin Amyloidosis by Stabilizing Transthyretin Tetramers and Disrupting Transthyretin Aggregates
por: Zou, Huizhen, et al.
Publicado: (2023)

How to Identify Transthyretin Cardiac Amyloidosis at an Early Stage
por: Izumiya, Yasuhiro, et al.
Publicado: (2020)

Non‐Val30Met mutation, septal hypertrophy, and cardiac denervation in patients with mutant transthyretin amyloidosis
por: Hirakawa, Kyoko, et al.
Publicado: (2018)

Transthyretin cardiac amyloidosis in continental Western Europe: an insight through the Transthyretin Amyloidosis Outcomes Survey (THAOS)
por: Damy, Thibaud, et al.
Publicado: (2019)

Variation in amount of wild-type transthyretin in different fibril and tissue types in ATTR amyloidosis
por: Ihse, Elisabet, et al.
Publicado: (2010)

Wild type transthyretin cardiac amyloidosis in a young individual: A case report
por: Ghosh, Shreya, et al.
Publicado: (2021)

Incidence and predictors of worsening heart failure in patients with wild‐type transthyretin cardiac amyloidosis
por: Ladefoged, Bertil Thyrsted, et al.
Publicado: (2022)

Extracellular Vesicles Contribute to the Metabolism of Transthyretin Amyloid in Hereditary Transthyretin Amyloidosis
por: Yamaguchi, Hiroki, et al.
Publicado: (2022)

Frequency of hereditary transthyretin amyloidosis among elderly patients with transthyretin cardiomyopathy
por: Maestro‐Benedicto, Alba, et al.
Publicado: (2022)

Recent advances in transthyretin amyloidosis therapy
por: Ueda, Mitsuharu, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_1b9p1cl57qb276ufmn9vfjb5cp